CORRECTEDSeptember 15, 2016 // In a landmark study, prostate-cancer survival was not significantly different among men with localized disease in the 3 different treatment groups (prostatectomy, radiation, and monitoring), according to 10-year resultspublished todayin theNew England Journal of Medicine...
New prostate test detects 96% of cancers.Byline: ROGER DOBSON PROSTATE cancer testing, currently renowned for inaccurate results, is...By DobsonRoger
Another test is done on a blood sample to determine the level of a protein (prostate-specific antigen or PSA) produced by prostate cells. The PSA test may indicate a person has a higher chance of having prostate cancer but controversies about the test exist (see following slide). The patien...
The gleason scale is an important diagnostic tool to assess the progression of prostate cancer. If yourPSA test resultsand/or DRE (digital rectal exam) come up positive, the next course of action is usually a prostate biopsy (surgical removal of a small section of prostate cells). The result...
being tested for prostate cancer overall. For example: ‘I tried not to think about the PSA blood test’ (time-point 1); ‘I tried not to think about going for my biopsy’ (time-point 2); ‘I tried not to think about getting my biopsy results’ (time-point 3) and ‘I tried not...
Study data on the Prolaris test (Myriad Genetics, Inc., Salt Lake City) were published online ahead of print in the Journal of Urology (Feb. 10, 2014). "This study represents a great advance in the treatment of prostate cancer. The results from three different institutions show that Prola...
(special math test) is able to estimate a patient’s likelihood of having favorable pathology. This algorithm utilizes a patient’s risk using their National Comprehensive Cancer Network (NCCN) risk category (very low risk, low risk, intermediate risk) combined with the results of their 17 gene...
or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer i...
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010;11(8):725-732.PubMedGoogle ScholarCrossref 34. Luján M, Páez A, Angulo JC, et al. Prostate cancer incidence and mortality in the Spanish section of the European Randomized ...
This simple yet powerful test can provide you and your doctor with important insights to inform your prostate cancer journey, all from a single sample. Understanding your MyRisk Hereditary Cancer Test results Your MyRisk test results can provide valuable insights into your inherited prostate cancer ...